Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the ...
New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating ...
FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing ...
The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.
Pulmonary Rehabilitation Improves Respiratory Function in Ventilated Patients: Meta-Analysis Reveals
China: A new meta-analysis published in BMC Pulmonary Medicine found that pulmonary rehabilitation in mechanically ventilated ...
Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...
The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...
IPF affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition develops when lung tissue becomes ...
F-FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing ...
Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback